Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
AMXI-5001 / AtlasMedx
ATLAS-101, NCT04503265: A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies	Recruiting	1/2	122	US	AMXI-5001:Dose Escalation Phase I, Phase I, Dose Escalation, AMXI-5001:Dose Expansion Phase II, Phase II, Dose Expansion	AtlasMedx, Incorporated	Advanced Malignant Neoplasm, Breast Cancer, Ovarian Cancer, Homologous Recombination Deficiency, Prostate Cancer, Pancreatic Cancer	08/26	10/26